Abnormal retinal development in the Btrc null mouse.
Previous microarray analysis revealed beta-transducin repeat containing (Btrc) down-regulation in the retina of mouse embryos specifically lacking cholinergic amacrine cells (CACs) as a result of the absence of skeletal musculature and fetal ocular movements. To investigate the role of Btrc in the determination of retinal cell fate, the present study examined retinal morphology in Btrc-/- mouse fetuses. The Btrc-/- retina showed a normal number of cell layers and number of cells per layer with normal cell proliferation and apoptosis. However, there was a complete absence of CACs and a decrease in tyrosine hydroxylase-expressing amacrine cells. The population of other amacrine cell subtypes was normal, whereas that of the precursor cells was decreased. There was also a reduction in the number of retinal ganglion cells, whereas their progenitors were increased. These findings suggest a role for Btrc in regulating the eventual ratio of resulting differentiated retinal cell types.
Baguma-Nibasheka
Mark
M
Department of Anatomy and Neurobiology, Dalhousie University Faculty of Medicine, Halifax, Canada.
Kablar
Boris
B
D000109:Acetylcholine / Q000378:metabolism; D025042:Amacrine Cells / Q000166:cytology / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000502:physiology; D049109:Cell Proliferation; D051379:Mice; D018345:Mice, Knockout; D012160:Retina / Q000002:abnormalities / Q000166:cytology / Q000196:embryology; D012165:Retinal Ganglion Cells / Q000166:cytology / Q000378:metabolism; D013234:Stem Cells / Q000166:cytology / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D044844:beta-Transducin Repeat-Containing Proteins / Q000235:genetics / Q000378:metabolism
C471643:Btrc protein, mouse; D044844:beta-Transducin Repeat-Containing Proteins; D014446:Tyrosine 3-Monooxygenase; D000109:Acetylcholine
Science. 2000 Mar 17;287(5460):2032-6
10720333
Nat Rev Mol Cell Biol. 2004 Sep;5(9):739-51
15340381
Genome Biol. 2000;1(5):REVIEWS3002
11178263
Development. 2006 Nov;133(22):4439-50
17075007
Development. 1999 Feb;126(3):555-66
9876184
Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):33-8
16371461
Invest Ophthalmol Vis Sci. 2006 May;47(5):1785-93
16638982
Nature. 2008 Mar 20;452(7185):365-9
18354482
Genes Dev. 2001 Dec 1;15(23):3059-87
11731473
Nature. 2003 Nov 6;426(6962):87-91
14603323
Vision Res. 2003 Apr;43(8):859-65
12668055
J Comp Neurol. 2001 Jan 22;429(4):601-14
11135238
Cell. 1995 Mar 24;80(6):949-57
7697725
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8752-7
12843402
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3859-63
10097128
Curr Opin Neurobiol. 1999 Feb;9(1):37-46
10072376
Genes Dev. 1999 Feb 1;13(3):270-83
9990852
Brain Res. 1985 Jun;352(2):286-90
3896407
Cell. 2001 Apr 6;105(1):43-55
11301001
Mol Cell Biol. 2004 Sep;24(18):8184-94
15340078
Development. 2000 Aug;127(16):3593-605
10903183
Neuron. 2001 Jun;30(3):771-80
11430810
J Biol Rhythms. 2007 Oct;22(5):375-86
17876059
Dev Cell. 2003 Jun;4(6):813-26
12791267
Nat Genet. 2003 May;34(1):53-8
12692551
Mol Cell. 2006 Apr 7;22(1):1-4
16600864
Development. 1997 Jan;124(2):363-71
9053312
EMBO J. 1999 May 4;18(9):2401-10
10228155
Neuron. 2004 Sep 16;43(6):795-807
15363391
J Histochem Cytochem. 2007 Sep;55(9):963-74
17533218
Oncogene. 2005 Apr 18;24(17):2860-70
15838520
Cell. 1999 May 14;97(4):431-4
10338207
Nature. 2008 Mar 20;452(7185):370-4
18354483
Histol Histopathol. 2006 Dec;21(12):1331-7
16977584
Development. 1998 Mar;125(6):1059-66
9463352
Nature. 1997 Sep 25;389(6649):378-82
9311778
J Cell Biol. 2008 Apr 7;181(1):65-78
18378770
Dev Cell. 2003 Jun;4(6):799-812
12791266
J Biol Chem. 1999 Oct 15;274(42):29641-7
10514433
Dev Dyn. 2003 Mar;226(3):478-90
12619134
Nat Rev Mol Cell Biol. 2005 Jan;6(1):9-20
15688063
Nature. 2006 Jun 15;441(7095):898-901
16778892
Genes Dev. 1999 Mar 1;13(5):505-10
10072378
J Neurosci. 2007 Nov 14;27(46):12707-20
18003851
Int J Oncol. 2001 May;18(5):959-64
11295041
Development. 2005 Jan;132(2):311-22
15604100
Genes Dev. 2004 Nov 1;18(21):2573-80
15520277